159 related articles for article (PubMed ID: 25399537)
1. Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV.
Tan DH; Raboud JM; Szadkowski L; Yi TJ; Shannon B; Kaul R; Liles WC; Walmsley SL
AIDS Res Hum Retroviruses; 2015 Mar; 31(3):276-81. PubMed ID: 25399537
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.
Zheng L; Taiwo B; Gandhi RT; Hunt PW; Collier AC; Flexner C; Bosch RJ
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):153-60. PubMed ID: 25072610
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.
Tan DH; Raboud JM; Kaul R; Walmsley SL
BMJ Open; 2014 Jan; 4(1):e004210. PubMed ID: 24464523
[TBL] [Abstract][Full Text] [Related]
7. Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection.
Mesquita PMM; Preston-Hurlburt P; Keller MJ; Vudattu N; Espinoza L; Altrich M; Anastos K; Herold KC; Herold BC
J Infect Dis; 2017 Feb; 215(4):614-622. PubMed ID: 28007920
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers.
Bonato M; Galli L; Passeri L; Longo V; Pavei G; Bossolasco S; Bertocchi C; Cernuschi M; Balconi G; Merati G; Lazzarin A; La Torre A; Cinque P
BMC Infect Dis; 2017 Jan; 17(1):61. PubMed ID: 28077069
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
[TBL] [Abstract][Full Text] [Related]
10. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.
Tuluc F; Spitsin S; Tustin NB; Murray JB; Tustin R; Schankel LA; Wiznia A; Nachman S; Douglas SD
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):133-142. PubMed ID: 27615375
[TBL] [Abstract][Full Text] [Related]
11. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
12. Immune Activation by Mycobacterium tuberculosis in HIV-Infected and -Uninfected Subjects.
Wyndham-Thomas C; Corbière V; Selis E; Payen MC; Goffard JC; Van Vooren JP; Mascart F; Dirix V
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):103-111. PubMed ID: 27532475
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.
Tan DH; Raboud JM; Kaul R; Brunetta J; Kaushic C; Kovacs C; Lee E; Luetkehoelter J; Rachlis A; Smaill F; Smieja M; Walmsley SL
Clin Infect Dis; 2013 Aug; 57(3):448-57. PubMed ID: 23572481
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
[TBL] [Abstract][Full Text] [Related]
15. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4
Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L
J Virol; 2019 May; 93(9):. PubMed ID: 30787156
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.
Serwadda D; Gray RH; Sewankambo NK; Wabwire-Mangen F; Chen MZ; Quinn TC; Lutalo T; Kiwanuka N; Kigozi G; Nalugoda F; Meehan MP; Ashley Morrow R; Wawer MJ
J Infect Dis; 2003 Nov; 188(10):1492-7. PubMed ID: 14624374
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.
Roxby AC; Drake AL; John-Stewart G; Brown ER; Matemo D; Otieno PA; Farquhar C
PLoS One; 2011; 6(5):e19947. PubMed ID: 21637835
[TBL] [Abstract][Full Text] [Related]
19. Homing in on the cellular immune response to HSV-2 in humans.
Koelle DM; Gonzalez JC; Johnson AS
Am J Reprod Immunol; 2005 Apr; 53(4):172-81. PubMed ID: 15760378
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting.
Russell DB; Tabrizi SN; Russell JM; Garland SM
J Clin Virol; 2001 Oct; 22(3):305-13. PubMed ID: 11564596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
